Flora Growth (FLGC) Projected to Post Earnings on Monday

Flora Growth (NASDAQ:FLGC) is anticipated to announce its Q4 2025 results before the market opens on Monday, March 23rd. Analysts expect Flora Growth to post earnings of ($1.97) per share for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Friday, February 27, 2026 at 7:00 AM ET.

Flora Growth Stock Up 17.4%

FLGC stock opened at $9.64 on Friday. The stock has a market capitalization of $10.08 million, a PE ratio of -0.30 and a beta of 1.90. Flora Growth has a 52 week low of $5.86 and a 52 week high of $47.00. The firm has a 50 day moving average of $8.10 and a 200 day moving average of $11.63.

Wall Street Analysts Forecast Growth

FLGC has been the topic of a number of research analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Flora Growth in a report on Thursday, January 22nd. Wall Street Zen upgraded Flora Growth from a “sell” rating to a “hold” rating in a research note on Saturday, January 17th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $30.00.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Flora Growth stock. Geode Capital Management LLC grew its stake in Flora Growth Corp. (NASDAQ:FLGC) by 1.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 168,572 shares of the company’s stock after purchasing an additional 3,015 shares during the period. Geode Capital Management LLC owned about 29.16% of Flora Growth worth $98,000 at the end of the most recent quarter. Institutional investors and hedge funds own 36.01% of the company’s stock.

About Flora Growth

Flora Growth Corp (NASDAQ: FLGC) is a vertically integrated cannabis and hemp company engaged in the cultivation, extraction, formulation and distribution of cannabinoid-based products. Its portfolio encompasses a broad range of offerings, including oils, vape cartridges, edibles, topicals and patent-pending delivery systems designed for both medical and wellness applications.

Founded in 2018, Flora Growth has established cultivation and processing operations in Uruguay’s greenhouse hubs, complemented by extraction and formulation laboratories in Florida.